Anti Cancer Medicines
Showing 49–64 of 68 results
-
TABRECTA (capmatinib) tablets, for oral use
Read more -
TEGSEDI (inotersen) injection, for subcutaneous use.
Read more -
TEPEZZA (teprotumumab-trbw) for injection, for intravenous use Initial U.S. Approval: 2020
Read more -
TERLIVAZ (terlipressin) for injection
Read more -
TEVIMBRA (tislelizumab-jsgr) injection
Read more -
TRIKAFTA (elexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets), co-packaged for oral use. Initial U.S. Approval: 2019
Read more -
TRODELVY (sacituzumab govitecan-hziy) for injection, for intravenous use
Read more -
TRUQAP (capivasertib) tablets
Read more -
TUKYSA (tucatinib) tablets, for oral use
Read more -
UNITUXIN (dinutuximab) injection, for intravenous use
Read more -
Valamor (Ribociclib) Tablets
Read more -
VEGZELMA (bevacizumab-adcd) injection
Read more -
VISTOGARD (uridine triacetate) oral granules
Read more -
VITRAKVI (larotrectinib) oral solution
Read more -
VORAXAZE (glucarpidase) For Injection, for intravenous use. Initial U.S. Approval: 2012
Read more -
VOTRIENT (pazopanib) tablets. Initial U.S. Approval: 2009
Read more
